Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001854270-24-000037
Filing Date
2024-04-26
Accepted
2024-04-26 17:00:25
Documents
16
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A snti-20231231.htm   iXBRL 10-K/A 581658
2 EX-31.3 a2023123110kaex313.htm EX-31.3 6098
3 EX-31.4 a2023123110kaex314.htm EX-31.4 6048
  Complete submission text file 0001854270-24-000037.txt   865617

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT snti-20231231.xsd EX-101.SCH 2527
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT snti-20231231_lab.xml EX-101.LAB 36612
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT snti-20231231_pre.xml EX-101.PRE 21475
19 EXTRACTED XBRL INSTANCE DOCUMENT snti-20231231_htm.xml XML 4984
Mailing Address 2 CORPORATE DRIVE, FIRST FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 2 CORPORATE DRIVE, FIRST FLOOR SOUTH SAN FRANCISCO CA 94080 (650) 382-3281
Senti Biosciences, Inc. (Filer) CIK: 0001854270 (see all company filings)

EIN.: 862437900 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-40440 | Film No.: 24884940
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)